Press release
Biosimilars Market is projected to expand at a noteworthy CAGR of 14.1% and reach a size of US$ 100.5 Bn by the end of 2032
A biosimilar is a type of biologic medication that is highly similar to an existing, already-approved biologic. The biosimilars market refers to the sales and distribution of these medications, which are designed to offer patients and healthcare providers more affordable options compared to their reference biologics. This market is growing rapidly, with increased demand for cost-effective treatments for various chronic diseases and the expiry of patents for several biologics.Request For Free Sample Report of "Biosimilars Market"@ https://www.persistencemarketresearch.com/samples/2782
Biosimilars are intended to be interchangeable with their reference products, meaning they can be substituted for the reference product without the need for additional clinical studies. They are typically priced at a lower cost than the reference product, making them an attractive option for patients and healthcare providers.
Companies
Pfizer Inc.
Sandoz International GMBH
Eli Lily & Company
Hospira Inc.
Amgen, Inc.
Biocon Ltd.
Actavis, Inc.
Cipla Ltd.
Teva Pharmaceutical Industries, Ltd.
Reddy's Laboratories Ltd.
Buy Full Report Now@ https://www.persistencemarketresearch.com/checkout/2782
The global biosimilars market is expected to experience significant growth in the coming years, driven by factors such as the increasing prevalence of chronic diseases, the expiry of patents on many biologics, and the push for healthcare cost containment. However, the market also faces challenges such as regulatory hurdles and concerns about the safety and efficacy of biosimilars.
Regional Analysis
Geographical segmentation of the global biosimilars market is North America, Latin America, Europe, South Asia and Pacific, East Asia, and the Middle East and Africa.
The biosimilars industry was solely concentrated in the European market since 2006 when the first biosimilar was approved in the EU by the EMA (European Medicines Agency). Europe has been the first and the largest market for biosimilars, now followed by North America.
Owing to the ready availability of skilled labor, relatively lower manufacturing costs, and less complicated regulatory measures, the market for biosimilars in Asian countries is expected to witness significant growth in the near future. The biosimilars market is currently witnessing active growth in regions, such as China, India, and Korea. The number of biosimilar manufacturers within China is drastically surging, as a result of which the FDA of China recently developed and finalized the biosimilars guidelines confined to the market for biosimilars production, sale, and consumption across China.
Some of the leading Asian manufacturers are already trading approved biosimilar products in the EU. Several Asian market players are likely to get product approvals in Western markets over the forecast period.
Request Customization @ https://www.persistencemarketresearch.com/request-customization/2782
Biosimilars Industry Research by Category
By Product Type:
Recombinant Glycosylated Proteins
Recombinant Non-Glycosylated Proteins
By Application:
Hematology
Growth Hormone Deficiency
Oncology
Diabetes Autoimmune
Disease
Others
By Distribution Channel:
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
For More Premium Insights, Check out the Link:
Psoriasis Drugs Market - https://www.prnewswire.com/news-releases/psoriasis-drugs-market-is-predicted-to-progress-at-a-cagr-of-6-5-to-reach-a-valuation-of-us-21-48-bn-by-2031--301482350.html
Botulinum Toxin Market - https://www.prnewswire.com/news-releases/botulinum-toxin-market-is-set-to-expand-at-a-cagr-of-6-9-and-reach-a-valuation-of-us-10-7-bn-by-2031--301477267.html
Wearable Injectors Market - https://www.prnewswire.com/news-releases/wearable-injectors-market-expanding-at-a-cagr-of-around-11-8-over-the-forecast-period-2021-2031---persistence-market-research-301477856.html
Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com
About Us
Persistence Market Research's Expertise in Life Sciences and Transformational Health
Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic recommendations. Click here to learn more about how we zero in on the critical aspects of this industry.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biosimilars Market is projected to expand at a noteworthy CAGR of 14.1% and reach a size of US$ 100.5 Bn by the end of 2032 here
News-ID: 2916783 • Views: …
More Releases from Persistence Market Research
Europe Autogenous Vaccines Market Size to Hit US$ 108.3 Mn in 2025, Forecasted G …
According to Persistence Market Research, the Europe autogenous vaccines market size is projected to reach US$ 108.3 million in 2025 and expand to US$ 155.1 million by 2032, advancing at a CAGR of 5.3% during the forecast period. This market is witnessing robust growth due to rising emphasis on antimicrobial stewardship, precision herd health management, and farm-specific vaccination strategies. The movement away from preventive antibiotic use in livestock has created…
India Malaria Diagnostics Market Size to Reach US$ 81.6 Mn by 2032, Forecasted C …
The India malaria diagnostics market is witnessing steady growth on the back of government-led initiatives, strategic collaborations, and technological innovations. According to Persistence Market Research, the market size is projected to reach US$ 81.6 Mn in 2032 from US$ 61.6 Mn in 2025, expanding at a CAGR of 4.1% during the forecast period. Increasing adoption of advanced molecular diagnostics and rapid diagnostic tests (RDTs) has made early and accurate detection…
Serum Separation Gel Market Size to Reach US$ 12.56 Bn by 2032, Registers 6% CAG …
The global serum separation gel market is poised for steady growth, with its size projected to rise from US$ 7.88 billion in 2025 to US$ 12.56 billion by 2032, reflecting a CAGR of 6%. According to Persistence Market Research, this expansion is underpinned by factors such as the rising global disease burden, technological advancements in diagnostic testing, and a growing emphasis on preventive healthcare. Serum separation gels play a critical…
Cannabis Inhalers Market Size Expected to Hit US$10.2 Bn by 2032, Reports Persis …
The global cannabis inhalers market is emerging as one of the fastest-growing segments within the medical marijuana industry. According to estimates, the market is projected to reach US$6.1 Bn in 2025 and expand to US$10.2 Bn by 2032, reflecting a CAGR of 7.6% during the forecast period. This growth is fueled by the rising prevalence of chronic conditions such as cancer, arthritis, and neurological disorders, which have prompted patients and…
More Releases for Asia
Asia Private Equity Firm, Asia Private Equity Management, Asia Private Equity Se …
The private equity market in China has been rapidly growing in recent years. Private equity (PE) refers to the purchase of shares in a company that are not publicly traded on a stock exchange. PE firms typically target companies that are undervalued or in need of capital for growth, and aim to improve the company's operations and financial performance before selling it at a higher value.
https://boomingfaucet.com/
Asia Private Equity Consulting
E-mail:nolan@pandacuads.com
In China,…
South East Asia Business Jet Market And Top Key Players are Asia Corporate Jet, …
By 2022, the South East Asia Business Jet Markets estimated to reach US$ XX Mn, up from US$ XX Mn in 2016, growing at a CAGR of XX% during the forecast period. The Global Business Jet Market, currently at 21 million USD, contributes the highest share in the market and is poised to grow at the fastest rate in the future. The three broad categories of business jets are Small,…
LIXIL Asia Presents Asia Pacific Property Awards
Through its power brands GROHE and American Standard, LIXIL Asia signs a three-year deal to become the Headline Sponsor of the Asia Pacific Property Awards from 2019 until 2022.
23rd January 2019: The International Property Awards, first established in 1993, are open to residential and commercial property professionals from around the globe. They celebrate the highest levels of achievement by companies operating within the architecture, interior design, real estate and property…
PEOPLEWAVE WINS ASIA TECH PODCAST PITCHDECK ASIA 2019 AWARDS
15 January 2019, Singapore – Peoplewave, Asia’s leading data-driven HR technology company, won the Asia Tech Podcast (ATP) Pitchdeck Asia 2019 Awards, being awarded “Startup Most Likely to Succeed in 2019".
The 2019 Pitchdeck Asia Awards is an opportunity for the Asian Startup Ecosystem to shine a spotlight on some of its best startups. The awards were decided by a public vote. More than 7,200 votes were cast by registered LinkedIn…
Undersea Defence Technology Asia, UDT Asia 2011
Latest Military Diving Technologies featured in UDT Asia
Equipping Asia’s navies with the latest diving technology for asymmetric warfare and
operations
SINGAPORE, 17 October 2011 - Naval diving and underwater special operations is a field that is
seeing increased attention and investment amongst navies in Asia. Units such as the Indonesian Navy‟s KOPASKA, the Republic of Singapore Navy‟s Naval Diving Unit (NDU), the Royal Malaysian Navy‟s PASKAL are increasingly utilising specialised equipment for conducting…
Asia Diligence – Specialist Investigative Due Diligence for Asia & Beyond
Asia Diligence today announced the opening of its European Customer Services office in the United Kingdom. The office is to be managed by Steve Fowler and will focus on providing services to Asia Diligence’s European customers. Asia Diligence is also planning to open a US office in the near future, which will provide customer service to its US and North American clients.
Asked to comment on the move, Luke Palmer, the…
